Mirum Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | +74.0% | +302.7% | +141.8% | +80.8% | +54.7% | |
| – | – | +92.3% | +205.5% | +550.2% | +280.1% | +73.6% | +23.2% | |
| – | – | – | – | +275.3% | +115.4% | +83.2% | +64.8% | |
| – | +1,744.3% | +89.8% | +61.1% | -18.7% | -4.0% | +37.1% | +32.4% | |
| – | +1,239.3% | +93.1% | +120.4% | -66.1% | +723.1% | +36.6% | +34.8% | |
| – | +1,777.3% | +89.4% | +83.9% | +2.8% | +26.8% | +38.0% | +29.3% | |
| – | – | – | – | – | – | – | – | |
| – | – | -86.8% | +5,150.7% | -9.2% | -5.5% | -5.3% | +0.5% | |
| – | – | – | – | – | – | – | – | |
| – | – | -71.4% | +516.7% | -17,413.5% | – | +3.9% | +88.0% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.